Skip to main content

Table 3 The subgroup of the relationship and heterogeneity between high SNHG12 expression and tumor stage

From: Long noncoding RNA SNHG12 is a potential diagnostic and prognostic biomarker in various tumors

Subgroup analysis No. of studies No. of patients Pool OR (95% CI) Weight Heterogeneity random
Fixed Random I2 (%) p value
ORs of tumor stage subgroup 9 639 3.94 [2.80, 5.53] 3.91 [2.77, 5.51] 100% 0 0.46
Cancer type
 Digestive system 4 222 4.54 [2.58, 8.00] 4.54 [2.58, 8.00] 36.60% 0 0.76
 Respiratory system 1 129 3.79 [1.75, 8.19] 3.79 [1.75, 8.19] 20.00% - -
 Reproductive system 2 178 2.24 [1.19, 4.21] 2.24 [1.19, 4.21] 29.70% 0 0.87
 Nervous system 1 79 8.79 [3.17, 24.32] 8.79 [3.17, 24.32] 11.40% - -
 Locomotor system 1 31 10.89 [1.14, 103.98] 10.89 [1.14, 103.98] 2.30% - -
Cut-off
 Others 3   3.59 [1.83, 7.02] 3.79 [1.58, 9.07] 25.00% 28.5 0.247
 Median 6   4.07 [2.74, 6.03] 4.06 [2.73, 6.05] 75.00% 0 0.445
Sample size
 Size < 60 4 235 3.76 [2.11, 6.69] 3.69 [2.05, 6.62] 34.70% 0 0.48
 Size ≥ 60 5 404 4.04 [2.65, 6.14] 4.07 [2.50, 6.65] 65.30% 23 0.46
Quality scores
 Score < 80 4 269 2.70 [1.60, 4.54] 2.62 [1.55, 4.44] 42.70% 0 0.6
 Score ≥ 80 5 370 5.25 [3.34, 8.26] 5.25 [3.33, 8.28] 57.30% 0 0.73